ARCHIVES

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

UC Davis Becomes 41st Center to Earn NCI Comprehensive Designation

March 16, 2012

In Brief: Appropriations Bill Markups Due This Month, With Increases Seen For NCI, NIH, And AIDS

July 3, 1987

In Brief: Fischinger, SAIC Win $400 Million Contract

March 3, 1995

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

April 26, 2013

Business & Regulatory Report March edition (8 pages) included.

March 19, 2004

Cancer Mmeetings Lister For Next Three Months

February 23, 1996